These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 25959096)

  • 1. Bucindolol hydrochloride in atrial fibrillation and concomitant heart failure.
    Black-Maier E; Steinberg BA; Piccini JP
    Expert Rev Cardiovasc Ther; 2015 Jun; 13(6):627-36. PubMed ID: 25959096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics of Bucindolol in Atrial Fibrillation and Heart Failure.
    Parikh KS; Piccini JP
    Curr Heart Fail Rep; 2017 Dec; 14(6):529-535. PubMed ID: 28975475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bucindolol for the Maintenance of Sinus Rhythm in a Genotype-Defined HF Population: The GENETIC-AF Trial.
    Piccini JP; Abraham WT; Dufton C; Carroll IA; Healey JS; van Veldhuisen DJ; Sauer WH; Anand IS; White M; Wilton SB; Aleong R; Rienstra M; Krueger SK; Ayala-Paredes F; Khaykin Y; Merkely B; Miloradović V; Wranicz JK; Ilkhanoff L; Ziegler PD; Davis G; Emery LL; Marshall D; Kao DP; Bristow MR; Connolly SJ;
    JACC Heart Fail; 2019 Jul; 7(7):586-598. PubMed ID: 31042551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic drug evaluation of bucindolol for the treatment of atrial fibrillation in heart failure patients.
    Rosa GM; Meliota G; Brunelli C; Ferrero S
    Expert Opin Drug Metab Toxicol; 2017 Apr; 13(4):473-481. PubMed ID: 28162002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation.
    Kao DP; Davis G; Aleong R; O'Connor CM; Fiuzat M; Carson PE; Anand IS; Plehn JF; Gottlieb SS; Silver MA; Lindenfeld J; Miller AB; White M; Murphy GA; Sauer W; Bristow MR
    Eur J Heart Fail; 2013 Mar; 15(3):324-33. PubMed ID: 23223178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genotype-directed comparative effectiveness trial of Bucindolol and metoprolol succinate for prevention of symptomatic atrial fibrillation/atrial flutter in patients with heart failure: Rationale and design of the GENETIC-AF trial.
    Piccini JP; Connolly SJ; Abraham WT; Healey JS; Steinberg BA; Al-Khalidi HR; Dignacco P; van Veldhuisen DJ; Sauer WH; White M; Wilton SB; Anand IS; Dufton C; Marshall DA; Aleong RG; Davis GW; Clark RL; Emery LL; Bristow MR
    Am Heart J; 2018 May; 199():51-58. PubMed ID: 29754666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of atrial fibrillation by bucindolol is dependent on the beta₁389 Arg/Gly adrenergic receptor polymorphism.
    Aleong RG; Sauer WH; Davis G; Murphy GA; Port JD; Anand IS; Fiuzat M; O'Connor CM; Abraham WT; Liggett SB; Bristow MR
    JACC Heart Fail; 2013 Aug; 1(4):338-344. PubMed ID: 24159564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenergic receptor polymorphisms and prevention of ventricular arrhythmias with bucindolol in patients with chronic heart failure.
    Aleong RG; Sauer WH; Robertson AD; Liggett SB; Bristow MR
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):137-43. PubMed ID: 23275278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose Response of β-Blockers in Adrenergic Receptor Polymorphism Genotypes.
    Parikh KS; Fiuzat M; Davis G; Neely M; Blain-Nelson P; Whellan DJ; Abraham WT; Adams KF; Felker GM; Liggett SB; O'Connor CM; Bristow MR
    Circ Genom Precis Med; 2018 Aug; 11(8):e002210. PubMed ID: 30354340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta blockers improve outcome in patients with heart failure and atrial fibrillation: U.S. carvedilol study.
    Ramaswamy K
    Card Electrophysiol Rev; 2003 Sep; 7(3):229-32. PubMed ID: 14739719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β1- and α2C-adrenergic receptor polymorphisms and the antiarrhythmic effect of bucindolol in heart failure with reduced ejection fraction.
    Lymperopoulos A; Negussie S; Walklett K
    Pharmacogenomics; 2013 Oct; 14(13):1545-9. PubMed ID: 24088125
    [No Abstract]   [Full Text] [Related]  

  • 12. β-Blockers on Discharge From Acute Atrial Fibrillation Are Associated With Decreased Mortality and Lower Cerebrovascular Accidents in Patients With Heart Failure and Reduced Ejection Fraction.
    Abi Khalil C; Zubaid M; Asaad N; Rashed WA; Hamad AK; Singh R; Al Suwaidi J
    Angiology; 2018 Apr; 69(4):316-322. PubMed ID: 28737070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological management of atrial fibrillation in patients with heart failure with reduced ejection fraction: review of current knowledge and future directions.
    Grubb A; Mentz RJ
    Expert Rev Cardiovasc Ther; 2020 Feb; 18(2):85-101. PubMed ID: 32066285
    [No Abstract]   [Full Text] [Related]  

  • 14. Bucindolol Decreases Atrial Fibrillation Burden in Patients With Heart Failure and the
    Piccini JP; Dufton C; Carroll IA; Healey JS; Abraham WT; Khaykin Y; Aleong R; Krueger SK; Sauer WH; Wilton SB; Rienstra M; van Veldhuisen DJ; Anand IS; White M; Camm AJ; Ziegler PD; Marshall D; Bristow MR; Connolly SJ;
    Circ Arrhythm Electrophysiol; 2021 Aug; 14(8):e009591. PubMed ID: 34270905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Significance of Resting Heart Rate and Use of β-Blockers in Atrial Fibrillation and Sinus Rhythm in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Swedish Heart Failure Registry.
    Li SJ; Sartipy U; Lund LH; Dahlström U; Adiels M; Petzold M; Fu M
    Circ Heart Fail; 2015 Sep; 8(5):871-9. PubMed ID: 26243796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased Mortality With Beta-Blockers in Patients With Heart Failure and Coexisting Atrial Fibrillation: An AF-CHF Substudy.
    Cadrin-Tourigny J; Shohoudi A; Roy D; Talajic M; Tadros R; Mondésert B; Dyrda K; Rivard L; Andrade JG; Macle L; Guerra PG; Thibault B; Dubuc M; Khairy P
    JACC Heart Fail; 2017 Feb; 5(2):99-106. PubMed ID: 28089316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhythm control of atrial fibrillation in heart failure.
    Heijman J; Voigt N; Abu-Taha IH; Dobrev D
    Heart Fail Clin; 2013 Oct; 9(4):407-15, vii-viii. PubMed ID: 24054474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Blockers in Atrial Fibrillation Patients With or Without Heart Failure: Association With Mortality in a Nationwide Cohort Study.
    Nielsen PB; Larsen TB; Gorst-Rasmussen A; Skjøth F; Lip GY
    Circ Heart Fail; 2016 Feb; 9(2):e002597. PubMed ID: 26823497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-blockers and outcome in heart failure and atrial fibrillation: a meta-analysis.
    Rienstra M; Damman K; Mulder BA; Van Gelder IC; McMurray JJ; Van Veldhuisen DJ
    JACC Heart Fail; 2013 Feb; 1(1):21-8. PubMed ID: 24621795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiadrenergic therapy in the control of atrial fibrillation.
    Naccarelli GV
    J Cardiovasc Pharmacol Ther; 2005 Jun; 10 Suppl 1():S33-43. PubMed ID: 15965571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.